A detailed history of Moors & Cabot, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Moors & Cabot, Inc. holds 125,283 shares of JNJ stock, worth $20.3 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
125,283
Previous 126,932 1.3%
Holding current value
$20.3 Million
Previous $20.1 Million 8.81%
% of portfolio
0.99%
Previous 1.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$144.38 - $157.78 $238,082 - $260,179
-1,649 Reduced 1.3%
125,283 $18.3 Million
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $1.11 Million - $1.16 Million
7,154 Added 5.97%
126,932 $20.1 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $390,353 - $425,957
2,681 Added 2.29%
119,778 $18.8 Million
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $152,012 - $170,292
-976 Reduced 0.83%
117,097 $18.2 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $53,250 - $57,307
-345 Reduced 0.29%
118,073 $19.5 Million
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $478,073 - $570,522
-3,165 Reduced 2.6%
118,418 $18.4 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $1.6 Million - $1.79 Million
9,971 Added 8.93%
121,583 $21.5 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $1.91 Million - $2.14 Million
-11,908 Reduced 9.64%
111,612 $19.7 Million
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $993,631 - $1.11 Million
-6,159 Reduced 4.75%
123,520 $20.2 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $376,072 - $415,918
2,236 Added 1.75%
129,679 $23 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $620,225 - $704,351
3,922 Added 3.18%
127,443 $22.6 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $90,907 - $100,864
-583 Reduced 0.47%
123,521 $21.1 Million
Q3 2021

Dec 08, 2021

BUY
$161.5 - $179.47 $20 Million - $22.3 Million
124,104 New
124,104 $20 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $20.2 Million - $22.4 Million
-125,051 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $429,958 - $461,204
2,696 Added 2.2%
125,051 $20.6 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $484,313 - $539,398
-3,164 Reduced 2.52%
122,355 $20.1 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $347,573 - $398,958
-2,535 Reduced 1.98%
125,519 $19.8 Million
Q3 2020

Nov 09, 2020

BUY
$140.38 - $153.83 $1.15 Million - $1.26 Million
8,202 Added 6.84%
128,054 $19.1 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $2.32 Million - $2.8 Million
17,974 Added 17.64%
119,852 $16.9 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $1.55 Million - $2.15 Million
-13,969 Reduced 12.06%
101,878 $13.4 Million
Q4 2019

Jan 28, 2020

BUY
$127.5 - $146.44 $221,212 - $254,073
1,735 Added 1.52%
115,847 $16.9 Million
Q3 2019

Oct 22, 2019

SELL
$126.95 - $142.14 $1.13 Million - $1.26 Million
-8,885 Reduced 7.22%
114,112 $14.8 Million
Q2 2019

Jul 18, 2019

BUY
$131.15 - $144.24 $387,548 - $426,229
2,955 Added 2.46%
122,997 $17.1 Million
Q1 2019

May 06, 2019

SELL
$125.72 - $139.79 $15.1 Million - $16.8 Million
-120,042 Reduced 50.0%
120,042 $16.8 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $13.7 Million - $15.2 Million
108,648 Added 82.66%
240,084 $33.5 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $956,923 - $1.15 Million
-7,790 Reduced 5.6%
131,436 $17 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $471,973 - $554,660
3,882 Added 2.87%
139,226 $19.3 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $356,409 - $393,303
-2,985 Reduced 2.16%
135,344 $16.4 Million
Q1 2018

May 18, 2018

BUY
$125.1 - $148.14 $532,800 - $630,928
4,259 Added 3.18%
138,329 $17.7 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $955,937 - $1.05 Million
7,285 Added 5.75%
134,070 $18.7 Million
Q3 2017

Nov 16, 2017

BUY
$129.47 - $135.38 $2.14 Million - $2.23 Million
16,504 Added 14.97%
126,785 $16.5 Million
Q2 2017

Aug 15, 2017

BUY
N/A
110,281
110,281 $14.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.